Barclays PLC Biotechnology

Barclays PLC

  • $377 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
NVO
Novo Nordisk A S
PUT
$89.3 Million
750K
Q3 2024
Added 73.12%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$15.5 Million
56.3K
Q3 2024
Reduced 19.87%
BGNE
Bei Gene, Ltd.
CALL
$12.8 Million
57K
Q3 2024
Added 2.27%
BGNE
Bei Gene, Ltd.
PUT
$12.8 Million
57K
Q3 2024
Added 2.27%
VRTX
Vertex Pharmaceuticals Inc
PUT
$10.2 Million
21.9K
Q3 2024
Added 11.08%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$9.36 Million
8.9K
Q3 2024
Added 17.89%
CORT
Corcept Therapeutics Inc
PUT
$9.26 Million
200K
Q3 2024
Added 23.26%
ARGX
Argenx Se
CALL
$8.62 Million
15.9K
Q3 2024
New holding
VRTX
Vertex Pharmaceuticals Inc
CALL
$7.44 Million
16K
Q3 2024
Added 11.08%
SRPT
Sarepta Therapeutics, Inc.
CALL
$6.28 Million
50.3K
Q3 2024
Added 14.72%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$5.25 Million
19.1K
Q3 2024
Reduced 19.87%
IONS
Ionis Pharmaceuticals Inc
PUT
$4.01 Million
100K
Q3 2024
Added 3.47%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$3.79 Million
3.6K
Q3 2024
Added 17.89%
MRUS
Merus N.V.
PUT
$2.81 Million
56.3K
Q3 2024
Added 13.01%
BMRN
Biomarin Pharmaceutical Inc
PUT
$2.52 Million
35.9K
Q3 2024
Reduced 74.29%
ACLX
Arcellx, Inc.
PUT
$1.67 Million
20K
Q3 2024
Added 127.71%
ACLX
Arcellx, Inc.
CALL
$1.67 Million
20K
Q3 2024
Added 127.71%
BMRN
Biomarin Pharmaceutical Inc
CALL
$1.58 Million
22.5K
Q3 2024
Reduced 74.29%
KYMR
Kymera Therapeutics, Inc.
PUT
$1.49 Million
31.4K
Q3 2024
Added 86.9%
AGIO
Agios Pharmaceuticals, Inc.
CALL
$1.43 Million
32.2K
Q3 2024
Added 64.19%
CRSP
Crispr Therapeutics Ag
CALL
$1.41 Million
30K
Q3 2024
Added 97.88%
CRSP
Crispr Therapeutics Ag
PUT
$1.41 Million
30K
Q3 2024
Added 97.88%
MRNA
Moderna, Inc.
PUT
$1.34 Million
20K
Q3 2024
Added 14.41%
MRNA
Moderna, Inc.
CALL
$1.34 Million
20K
Q3 2024
Added 14.41%
VKTX
Viking Therapeutics, Inc.
PUT
$1.29 Million
20.4K
Q3 2024
Added 15.57%
FOLD
Amicus Therapeutics, Inc.
PUT
$1.22 Million
114K
Q3 2024
Added 41.51%
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$1.04 Million
45K
Q3 2024
Added 54.97%
ARCT
Arcturus Therapeutics Holdings Inc.
PUT
$1.04 Million
45K
Q3 2024
Added 54.97%
PTCT
Ptc Therapeutics, Inc.
PUT
$779,000
21K
Q3 2024
Added 157.44%
PTCT
Ptc Therapeutics, Inc.
CALL
$779,000
21K
Q3 2024
Added 157.44%
BEAM
Beam Therapeutics Inc.
PUT
$735,000
30K
Q3 2024
Added 123.9%
BEAM
Beam Therapeutics Inc.
CALL
$735,000
30K
Q3 2024
Added 123.9%
SRPT
Sarepta Therapeutics, Inc.
PUT
$624,000
5K
Q3 2024
Added 14.72%
SAVA
Cassava Sciences Inc
PUT
$589,000
20K
Q3 2024
Added 251.59%
RCKT
Rocket Pharmaceuticals, Inc.
CALL
$554,000
30K
Q3 2024
Added 18.48%
RCKT
Rocket Pharmaceuticals, Inc.
PUT
$554,000
30K
Q3 2024
Added 18.48%
CYTK
Cytokinetics Inc
PUT
$528,000
10K
Q3 2024
Added 33.51%
CYTK
Cytokinetics Inc
CALL
$528,000
10K
Q3 2024
Added 33.51%
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$484,000
25K
Q3 2024
Added 153.64%
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$484,000
25K
Q3 2024
Added 153.64%
PCVX
Vaxcyte, Inc.
CALL
$480,000
4.2K
Q3 2024
Added 63.93%
DAWN
Day One Biopharmaceuticals, Inc.
CALL
$418,000
30K
Q3 2024
Added 143.5%
DAWN
Day One Biopharmaceuticals, Inc.
PUT
$418,000
30K
Q3 2024
Added 143.5%
PLRX
Pliant Therapeutics, Inc.
PUT
$336,000
30K
Q3 2024
Added 22.91%
PLRX
Pliant Therapeutics, Inc.
CALL
$336,000
30K
Q3 2024
Added 22.91%
TERN
Terns Pharmaceuticals, Inc.
CALL
$287,000
34.4K
Q3 2024
Reduced 51.44%
KYMR
Kymera Therapeutics, Inc.
CALL
$260,000
5.5K
Q3 2024
Added 86.9%
BCRX
Biocryst Pharmaceuticals Inc
PUT
$76,000
10K
Q3 2024
Added 110.37%
IMVT
Immunovant, Inc.
PUT
$3,000
100
Q3 2024
Added 121.26%
Filter Shares Options
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email